Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Chinese Journal of Oncology ; (12): 299-301, 2011.
Article in Chinese | WPRIM | ID: wpr-303330

ABSTRACT

<p><b>OBJECTIVE</b>To observe the local control rate, survival time and side effect of three-dimensional conformal radiation therapy combined with Tegafur for postoperative recurrent rectal carcinoma.</p><p><b>METHODS</b>Forty patients with postoperative recurrent rectal carcinoma received three-dimensional conformal radiation therapy, 1.8 - 2.0 Gy/once, 5 times every week and the total dose was 54 - 65 Gy. At the same time, the patients took Tegafur orally 40 mg/m(2) twice per day for consecutive 28 days, and one cycle lasted for 42 days. The chemotherapy was applied for 2 cycles after radiotherapy.</p><p><b>RESULTS</b>The total effective rate (CR + PR) was 70.0%, improvement rate was 90.0%, 1-year survival rate was 70.0%, and 1-year local control rate was 62.5%. There was only a little side effect.</p><p><b>CONCLUSIONS</b>Three-dimensional conformal radiation therapy combined with Tegafur for postoperative recurrent rectal carcinoma have definite effect, with a high local control rate, and patients well tolerance the treatment without serious side effect. It can apparently improve the life quality of the patients.</p>


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Adenocarcinoma , Drug Therapy , Radiotherapy , General Surgery , Antimetabolites, Antineoplastic , Therapeutic Uses , Combined Modality Therapy , Diarrhea , Exanthema , Leukopenia , Neoplasm Recurrence, Local , Neoplasm Staging , Postoperative Period , Quality of Life , Radiotherapy, Conformal , Rectal Neoplasms , Drug Therapy , Radiotherapy , General Surgery , Remission Induction , Survival Rate , Tegafur , Therapeutic Uses
SELECTION OF CITATIONS
SEARCH DETAIL